Mutations within the putative signal sequence of the TGFBR1 gene have been identified in a small cohort of CLL patients and found to correlate with resistance to growth inhibitory effects of TGFB [100]. The gene discussed is TGFB1; the disease is B-cell chronic lymphocytic leukemia.